A previously healthy 28-year-old man presented with a rash for 1 month. He had taken griseofulvin for a week prior to rash onset. He had visited two ERs and was given minocycline and valacyclovir, followed by acyclovir, hydroxyzine and low-dose oral lesions were present. Lab test results demonstrated WBC 10.2 K/cmm with 8.4% eosinophils. Perilesional skin biopsy showed spongiotic dermatitis with eosinophils, with direct immunofluorescence positive for subepidermal IgG and C3 depositions consistent with bullous pemphigoid. He was treated with oral prednisone and clobetasol ointment, with improvement.
A previously healthy 28-year-old man presented with a rash for 1 month. He had taken griseofulvin for a week prior to rash onset. He had visited two ERs and was given minocycline and valacyclovir, followed by acyclovir, hydroxyzine and low-dose oral lesions were present. Lab test results demonstrated WBC 10.2 K/cmm with 8.4% eosinophils. Perilesional skin biopsy showed spongiotic dermatitis with eosinophils, with direct immunofluorescence positive for subepidermal IgG and C3 depositions consistent with bullous pemphigoid. He was treated with oral prednisone and clobetasol ointment, with improvement. 1 Over 50 agents have been implicated as a cause of drug-induced bullous pemphigoid (DIBP), including diuretics, ACE inhibitors, and antibiotics. [2] [3] [4] [5] Unlike classic bullous pemphigoid, DIBP occurs in younger patients, and relapses are rare. 3 Eosinophilia is often seen on lab tests, and symptoms may persist for up to 3 months after drug exposure. In our patient, griseofulvin was suspected as the trigger. Vesicular lesions are often misdiagnosed as herpetic infection, which may delay diagnosis and management. DIBP should 
